Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR).
Tanaka A, Vaduganathan M, Imai T, Okada Y, Sonoda S, Torimoto K, Suwa S, Teragawa H, Miyazono M, Fukuda M, Yonezu K, Takahashi N, Yoshida Y, Tanaka K, Shimabukuro M, Hotta Y, Moroi M, Niikura H, Kida K, Yokota K, Fukuda D, Tanabe K, Horiuchi Y, Toyoda S, Taguchi I, Yoshida H, Miyoshi T, Nangaku M, Shibata H, Node K; FIVE-STAR Investigators.
Tanaka A, et al. Among authors: yoshida y.
Cardiovasc Diabetol. 2025 Dec 5;24(1):454. doi: 10.1186/s12933-025-03014-x.
Cardiovasc Diabetol. 2025.
PMID: 41351003
Free PMC article.
Clinical Trial.